New study in @amjtransplant, from CCTI Researcher Paula Alonso-Guallart, DVM, characterizes biology/function/epigenetics of four clinically-applicable polyclonal regulatory T cell expansion protocols for translational applications in Cynomolgus macaque. #transplantation, #tolerance, #chimerism, #treg, #preclinicalstudies https://lnkd.in/dCzKcQe
About us
The Columbia Center for Translational Immunology (CCTI) at Columbia University Medical Center is a multi-departmental, multidisciplinary research center aimed at optimizing translation of advances in basic immunology from the laboratory to the clinic, understanding immunological diseases and events in humans and optimizing transfer of information and methodologies to achieve synergy between different disciplines of applied immunology. Columbia has the largest organ transplant program in the country, and a major reason for establishing the CCTI was the need for an in-depth laboratory research program focused around the extraordinary potential provided by this clinical program. The Center was established in April 2010 and currently includes 15 faculty members, including 13 Principal Investigators. The CCTI includes laboratories working in various areas of organ transplantation, hematopoietic cell transplantation, Type I diabetes, other areas of autoimmunity, tumor immunology, stem cell biology and basic immunology.
- Website
-
http://www.cumc.columbia.edu/ccti/
External link for Columbia Center for Translational Immunology
- Industry
- Higher Education
- Company size
- 51-200 employees
- Headquarters
- New York
- Founded
- 2010
- Specialties
- Transplantation, Immunology, Treg, Islets, and Chimerism
Updates
-
Annually, the Center for Translational Immunology is well represented at the Federation of Clinical Immunology Societies (FOCIS) and 2024 is no different. This year's FOCIS meeting is being held June 18-21 at the San Francisco Marriot Marquis in San Francisco, CA. The below link has a comprehensive list of CCTI presenters including date, location and time slots. https://lnkd.in/erZvrMQF
CCTI Presenters at the 2024 FOCIS Annual Meeting
vagelos.columbia.edu
-
Amazing work in transplantation ('natch) happening at the CCTI!
The CCTI Lands Four Nelson Family Transplant Innovation Awards
vagelos.columbia.edu
-
In an editorial in the most recent issue of the journal Xenotransplantation, Dr. Sachs reflects on his 30 years as a pioneer in the field and discusses his thoughts on its future. Dr. Sachs is best known for his discovery of MHC class II and for his seminal studies in the fields of transplant immune tolerance and xenotransplantation. https://lnkd.in/eN4EYP-T
Xenotransplantation at 30 years – A personal reminiscence and some thoughts for the future
onlinelibrary.wiley.com
-
Our latest publication in eBiosciences in which the authors show that understanding the formation of the human tissue resident memory T cell (TRM) repertoire requires longitudinal access to human non-lymphoid tissues. https://lnkd.in/eG3ETFnQ
Explore scientific, technical, and medical research on ScienceDirect
sciencedirect.com
-
And the CCTI is leading the way!
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
cnbc.com